Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001827722-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-15 | TARS | Goldberg Andrew D. | Dir | P - Purchase | $18.96 | +1,000 | 3,000 | +50% | +$19.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | P | A | 1,000 | $18.96 | 3,000 | D | — | — |